Bayer AG Valuation
| BAYZF Stock | USD 20.83 0.02 0.1% |
At this time, the firm appears to be fairly valued. Bayer AG shows a prevailing Real Value of $20.17 per share. The current price of the firm is $20.83. Our model approximates the value of Bayer AG from analyzing the firm fundamentals such as Profit Margin of 0.09 %, return on equity of 0.13, and Current Valuation of 87.41 B as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Bayer AG's price fluctuation is not too volatile at this time. Calculation of the real value of Bayer AG is based on 3 months time horizon. Increasing Bayer AG's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Bayer pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Bayer AG. Since Bayer AG is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bayer Pink Sheet. However, Bayer AG's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 20.83 | Real 20.17 | Hype 20.81 | Naive 18.71 |
The real value of Bayer Pink Sheet, also known as its intrinsic value, is the underlying worth of Bayer AG Company, which is reflected in its stock price. It is based on Bayer AG's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Bayer AG's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Bayer AG helps investors to forecast how Bayer pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bayer AG more accurately as focusing exclusively on Bayer AG's fundamentals will not take into account other important factors: Bayer AG Total Value Analysis
Bayer AG is currently forecasted to have takeover price of 87.41 B with market capitalization of 64.24 B, debt of 35.55 B, and cash on hands of 8.19 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Bayer AG fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
87.41 B | 64.24 B | 35.55 B | 8.19 B |
Bayer AG Investor Information
About 47.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.36. Some equities with similar Price to Book (P/B) outperform the market in the long run. Bayer AG has Price/Earnings To Growth (PEG) ratio of 1.31. The entity recorded earning per share (EPS) of 5.13. The firm last dividend was issued on the 2nd of May 2022. Bayer AG had 503:495 split on the 6th of June 2018. Based on the key indicators obtained from Bayer AG's historical financial statements, Bayer AG is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Bayer AG Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Bayer AG has an asset utilization ratio of 36.66 percent. This implies that the Company is making $0.37 for each dollar of assets. An increasing asset utilization means that Bayer AG is more efficient with each dollar of assets it utilizes for everyday operations.Bayer AG Ownership Allocation
Bayer AG holds a total of 982.42 Million outstanding shares. 30% of Bayer AG outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Bayer AG Profitability Analysis
The company reported the revenue of 44.08 B. Net Income was 1000 M with profit before overhead, payroll, taxes, and interest of 27.04 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Bayer AG's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Bayer AG and how it compares across the competition.
About Bayer AG Valuation
The pink sheet valuation mechanism determines Bayer AG's current worth on a weekly basis. Our valuation model uses a comparative analysis of Bayer AG. We calculate exposure to Bayer AG's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Bayer AG's related companies.Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany. Bayer Ag is traded on OTC Exchange in the United States.
8 Steps to conduct Bayer AG's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Bayer AG's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Bayer AG's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Bayer AG's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Bayer AG's revenue streams: Identify Bayer AG's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Bayer AG's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Bayer AG's growth potential: Evaluate Bayer AG's management, business model, and growth potential.
- Determine Bayer AG's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Bayer AG's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Bayer AG Growth Indicators
Investing in growth stocks can be very risky. If the company such as Bayer AG does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 982.4 M | |
| Quarterly Earnings Growth Y O Y | 5.424 | |
| Forward Price Earnings | 6.5876 | |
| Retained Earnings | 13.3 B |
Complementary Tools for Bayer Pink Sheet analysis
When running Bayer AG's price analysis, check to measure Bayer AG's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bayer AG is operating at the current time. Most of Bayer AG's value examination focuses on studying past and present price action to predict the probability of Bayer AG's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bayer AG's price. Additionally, you may evaluate how the addition of Bayer AG to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stocks Directory Find actively traded stocks across global markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |